Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis in Children”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Post-approval studies (Phase 4)Study completedNCT00161967
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 375
Post-approval studies (Phase 4)WithdrawnNCT03192371
What this trial is testing

Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children

Who this might be right for
Virus Diseases
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00161850
What this trial is testing

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Post-approval studies (Phase 4)Study completedNCT00463684
What this trial is testing

Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age

Who this might be right for
Japanese Encephalitis
PATH 278
Large-scale testing (Phase 3)Study completedNCT01408537
What this trial is testing

Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children

Who this might be right for
Encephalitis, Japanese B
Mahidol University 152
Large-scale testing (Phase 3)Study completedNCT01900444
What this trial is testing

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 119
Post-approval studies (Phase 4)UnknownNCT04817917
What this trial is testing

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

Who this might be right for
Japanese EncephalitisVaccine Preventable DiseaseVaccine Reaction
Zhejiang Provincial Center for Disease Control and Prevention 712
Post-approval studies (Phase 4)Study completedNCT00452621
What this trial is testing

Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years

Who this might be right for
Encephalitis, Tick-Borne
Novartis 235
Not applicableStudy completedNCT00163618
What this trial is testing

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Large-scale testing (Phase 3)Study completedNCT00840801
What this trial is testing

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 302
Post-approval studies (Phase 4)Study completedNCT00311441
What this trial is testing

Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children

Who this might be right for
Encephalitis, Tick-Borne
Novartis 300
Post-approval studies (Phase 4)Study completedNCT02532569
What this trial is testing

Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj

Who this might be right for
Japanese Encephalitis
Boryung Pharmaceutical Co., Ltd 94
Large-scale testing (Phase 3)Study completedNCT00161863
What this trial is testing

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Who this might be right for
Tick-borne Encephalitis
Pfizer
Large-scale testing (Phase 3)Study completedNCT01150942
What this trial is testing

Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea

Who this might be right for
Japanese Encephalitis
Boryung Pharmaceutical Co., Ltd 205
Large-scale testing (Phase 3)Study completedNCT01190228
What this trial is testing

Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV

Who this might be right for
Japanese EncephalitisVaricella
Sanofi Pasteur, a Sanofi Company 454
Not applicableNot Yet RecruitingNCT07830927
What this trial is testing

Early Neurological Outcome in Pediatric Encephalitis

Who this might be right for
EncephalitisBrain DiseasesNeurologic Manifestations
Assiut University 88
Large-scale testing (Phase 3)Study completedNCT03282370
What this trial is testing

Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 655
Testing effectiveness (Phase 2)Study completedNCT03204227
What this trial is testing

Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 220
Testing effectiveness (Phase 2)Study completedNCT00621764
What this trial is testing

Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

Who this might be right for
Japanese EncephalitisHepatitis A
Sanofi Pasteur, a Sanofi Company 300
Testing effectiveness (Phase 2)Study completedNCT00161889
What this trial is testing

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Next Page